Balefire, LLC
Source: SEC Form 13F · as of Mar 2026Balefire, LLC holds 22 biotech & pharma companies tracked by BioSniper, totaling $21.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
22
Total value held
$21.6M
| Company | Shares | Value |
|---|---|---|
| PMPhilip Morris International Inc | 21,476 | $3.6M |
| IQVIQVIA Holdings Inc. | 16,467 | $2.8M |
| LLYELI LILLY & Co | 2,087 | $1.9M |
| SHCSotera Health Company | 102,934 | $1.5M |
| CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 8,022 | $1.4M |
| JNJJOHNSON & JOHNSON | 5,364 | $1.3M |
| AMGNAMGEN INC | 3,360 | $1.2M |
| BMYBRISTOL MYERS SQUIBB CO | 17,935 | $1.1M |
| MRKMerck & Co., Inc. | 8,819 | $1.1M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 3,045 | $824K |
| ABBVAbbVie Inc. | 3,561 | $774K |
| UTHRUNITED THERAPEUTICS Corp | 1,241 | $736K |
| GILDGILEAD SCIENCES, INC. | 4,766 | $664K |
| AZNASTRAZENECA PLC | 2,334 | $460K |
| ELVElevance Health Inc. | 1,558 | $456K |
| ABTABBOTT LABORATORIES | 4,227 | $434K |
| PFEPFIZER INC | 12,462 | $350K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 764 | $341K |
| ZTSZoetis Inc. | 1,996 | $236K |
| MEDPMedpace Holdings Inc. | 451 | $217K |
| NVSNovartis AG | 1,385 | $212K |
| ANNXAnnexon, Inc. | 15,000 | $83K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.